#U.S. Tumor Ablation Market Size
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
The Tumblr office adopted Tommy, an 11-year-old Pomeranian.
Text
According to latest study, the U.S. Tumor Ablation market size is calculated at USD 579.76 million for 2024 and is expected to reach around USD 1,841.15 million by 2033, growing at a CAGR of 13.7 % from 2024 to 2033
0 notes
Text
Tumor Ablation Market Report Size And Share Report, 2030
The Insight Partners conducted market research on the "Global Tumor Ablation Market Share, Size and Trends | 2030" In recent times, there have been waves of change in the Tumor Ablation market. This research provides accurate estimates based on a thorough examination of several aspects affecting the company. This study presents realistic revenue, market size, and compound annual growth rate (CAGR) estimates for the Tumor Ablation market based on the current state of the market. The innovative Tumor Ablation market research, which has a foundation based on reality, is currently on sale. This market study can influence broad decision-making and steer companies on the proper path.
Enterprises operating in a very competitive Tumor Ablation market may encounter many obstacles. Investing in start-up businesses is no longer only based on gut feeling. Having reliable market research is always advised, regardless of experience level. The next chapters of market research provide you with a thorough review of local, regional, and global circumstances.
Know the Tumor Ablation Market Inside Out
This chapter covers several variables that affect business. Future expectations for the Tumor Ablation market are combined with the economies of scale delineated by market size, growth rate, and compound annual growth rate. To examine demand drivers and constraints before other market actors, this chapter is even more crucial. Companies may better manage their goods and place themselves in the market gap by understanding market trends.
Analysis of the business environment based on several models is provided in this section. Businesses must streamline their success and income streams to be competitive in the Tumor Ablation industry. Businesses may map the economic, environmental, and legal issues and update their unique selling propositions.
Analyzing Business During and After COVID-19
A historic COVID-19 pandemic was followed by the brief closure of companies. Tumor Ablation Market participants had to contend with poor marketing performance, lower revenues, and difficulties surviving their manufacturing lifecycles. Maintaining supply-demand balance and controlling expectations proved to be difficult for small and medium-sized businesses. This section discusses the examination of COVID-19's effects on companies and the alternate strategies they have employed to deal with the interruptions caused by the epidemic. This chapter also discusses the potential for recovery following COVID-19.
Market Segmentation
Tumor Ablation market research report is segmented as follows.Based on By Technology this market is categorized further into-
Cryoablation
Radiofrequency (RF) Ablation
Microwave Ablation and Others
Based on Application this market is categorized further into-
Lung Cancer
Liver Cancer
Kidney Cancer
Bone Metastasis and Others
Based on Geography this market is categorized further into-
North America
Europe
Asia Pacific
and South and Central America
Based on Regions:
North America (U.S., Canada, Mexico)
Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
Latin America (Brazil, Rest of Latin America)
The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)
Rest of the World…
Competitive Business Matrix
The competitor's analysis offered in this report emphasizes covering key companies in the Tumor Ablation market. A brief discussion of leading market players and their business strategies intends to offer essential details needed for a competitive edge.
Key companies in Tumor Ablation market are:
HEALTHTRONICS, INC.
BOSTON SCIENTIFIC CORPORATION
MISONIX, INC.
MERMAID MEDICAL A/S
NEUWAVE MEDICAL, INC.
MEDTRONIC, PLC
ANGIODYNAMICS, INC.
GALIL MEDICAL, INC.
EDAP TMS S.A.
SONACARE MEDICAL LLC
Strategic Outlook and TIP Recommendations
Strategic planning is essential to the success of any firm. The strategic advice in this area is essential for investors and enterprises. A company that has a forward-thinking, forward-focused vision endures through good times and bad. Understanding the components of the business environment enables organizations to take strategic actions when and where they are needed. Summary:
Market Size & Forecast by Revenue | 2030
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation – A detailed analysis by product, types, end-user, applications, segments, and geography
Competitive Landscape – Top key vendors and other prominent vendors
About Us:
The Insight Partners a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.
0 notes
Text
Surgical Tumor Ablation Market Demands, Analysis, Size, Trends, Revenue by 2028
Global Surgical Tumor Ablation Market, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Liver Cancer, Brain Cancer, Lung Cancer, Prostate Cancer, Bone Metastasis, Others), End User (Hospital, Surgical and Ablation Centers, Research Institute, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
In the consistent Surgical Tumor Ablation market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Surgical Tumor Ablation industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Surgical Tumor Ablation market report brings precise and exact market research information that drives business into the right direction.
Key Players
Aesculap, Inc. (U.S.)
Braun Melsungen AG (Germany)
Corin Group (U.K.)
Medical Devices Business Services, Inc. (U.S.)
Smith+ Nephew (U.K.)
Stryker (U.S.)
Zimmer Biomet (U.S.)
Exactech, Inc. (U.S.)
Medacta International (U.S.)
MicroPort Orthopedics Inc. (Switzerland)
Medtronic (U.S.)
Browse More Info @ https://www.databridgemarketresearch.com/reports/global-surgical-tumor-ablation-market
The research studies entailed in the winning Surgical Tumor Ablation market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.
Key questions answered in the report:
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
Report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Surgical Tumor Ablation Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Table Of Content
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Market
Part 04: Global Market Size
Part 05: Global Market Segmentation By Product
Part 06: Five Forces Analysis
More Reports:
Diuretic Drugs Market
Patient Engagement Technology Market
Healthcare Business Intelligence Market
Chinese Hamster Ovary cells (CHO) Market
Anti-cancer Drug Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
0 notes
Text
Ablation Devices Market to 2028 - Size, Forecast, Insights, and Competitive Landscape
Ablation Devices Market is grow at a CAGR 11.25% in the forecast 2021 to 2028.
Ablation Devices Market Scope and Size
· On the basis of product, the ablation devices market is segmented into laser ablators, radiofrequency ablators, microwave ablators, ultrasound ablators, electric ablators, hydrothermal ablators and cryoablators. Laser ablators have further been segmented into excimer laser ablators and cold laser ablators. Radiofrequency ablators have further been segmented into temperature-controlled radiofrequency ablators, fluid-cooled radiofrequency ablators and robotic catheter manipulation systems. Ultrasound ablators have further been segmented into high-intensity focused ultrasound (HIFU) ablators, magnetic resonance-guided focused ultrasound (MRGFUS) ablators, ultrasonic surgical ablation systems and extracorporeal shockwave lithotripsy (ESWL) systems. Electric ablators have further been segmented into argon plasma/beam coagulators and irreversible electroporation ablators. Hydrothermal ablators have further been segmented into endometrial hydrothermal balloon ablation devices. Microwave ablators have further been segmented into microwave thermotherapy devices. Cryoablators have further been segmented into tissue contact probes, tissue spray probes and epidermal and subcutaneous cryoablation devices.
· On the basis of technology type, the ablation devices market is segmented into radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation and others.
· On the basis of function, the ablation devices market is segmented into automatic and robotic.
· On the basis of procedure, the ablation devices market is segmented into tumor ablation, varicose veins, atrial fibrillation and aesthetics-skin rejuvenation and tightening, laser and other energy based therapies.
Get the sample copy of Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ablation-devices
Global Ablation Devices Market Country Level Analysis
The ablation devices market is analyzed and market size insights and trends are provided by country, product, technology type, function, procedure and application as referenced above.
The countries covered in the global ablation devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Competitive Landscape and Ablation Devices Market Share Analysis
The ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to ablation devices market.
MAJOR TOC OF THE REPORT
Chapter One: Ablation Devices Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three : Ablation Devices Market Competition, by Players
Chapter Four: Global Ablation Devices Market Size by Regions
Chapter Five: North Ablation Devices Market by Countries
Chapter Six: Europe Ablation Devices Market Revenue by Countries
Chapter Seven: Asia- Ablation Devices Market Revenue by Countries
Chapter Eight: South America Ablation Devices Market Revenue by Countries
Chapter Nine: Middle East and Ablation Devices Market Revenue Equipment by Countries
Chapter Ten: Global Ablation Devices Market Segment by Type
Chapter Eleven: Global Ablation Devices Market Segment by Application
Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-ablation-devices-market
The major players covered in the ablation devices market report are Varian Medical Systems Inc., Biosense Webster, Inc., Elekta AB, Medtronic, Johnson & Johnson Services, Inc., Alcon, Bausch & Lomb Pvt Ltd., EDAP TMS, Halyard, Olympus Corporation, Abbott, AngioDynamics, AtriCure, Inc., Boston Scientific Corporation and CONMED Corporation among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Access Full Report https://www.databridgemarketresearch.com/reports/global-ablation-devices-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
Stem Cell manufacturing Market
Revenue Cycle Management (RCM) Market
0 notes
Text
Tumor Ablation Market Anticipated To Show Healthy Growth And Be Worth $2.4 Billion By 2028
The global tumor ablation market size is estimated to reach USD 2.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.2% from 2021 to 2028. The increasing incidence of cancer and high demand for effective treatment options are the major factors driving the market growth. According to Cancer Research U.K., the incidence rate of cancer is expected to grow by 62.0% from 2018 to 2040. Lung, breast, bowel, and prostate are the most common sites reported with cancer in 2018.
Increasing inclination towards minimally invasive procedures owing to benefits such as speedy recovery, patient comfort, and shorter turnaround time are the factors expected to foster the demand for advanced tumor ablation techniques during the forecast period. Integration of tumor ablation devices with efficient interventional imaging modalities such as ultrasound, MRI, and CT is anticipated to revolutionize ablation procedures performed in outpatient settings. This is expected to significantly eliminate the cost to the patient including hospital stays.
Supportive government initiatives such as screening programs, awareness campaigns, and cancer schemes for various cancer types are expected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) started offering lung cancer screening programs in some areas of England. Such initiatives are anticipated to escalate the need for cancer management in the early cancer stages, thereby driving the market.
The rising demand for advanced medical technologies coupled with improving financing capabilities of healthcare facilities is expected to increase the demand for medical devices being used for the treatment of tumors, during the forecast period. For instance, Maimonides Medical Centre, New York announced the purchase of advanced High Intensity Focused Ultrasound (HIFU) ablation device (Focal One by EDAP TMS SA) in 2019, becoming the second hospital in the U.S. to be equipped with HIFU technology.
Request a free sample copy or view report summary: Tumor Ablation Market Report
Tumor Ablation Market Report Highlights
Radiofrequency dominated the technology segment and accounted for the largest revenue share of 35.5% in 2020 owing to prominent application in solid tumor removal
Percutaneous procedures are expected to witness lucrative growth over the forecast period due to rising demand for minimally invasive procedures offering faster recovery and higher safety
The lung cancer segment is anticipated to witness the fastest growth over the forecast period
A sedentary lifestyle, increasing incidences of smoking, and rising air pollution are the factors contributing to the growing prevalence of lung cancer
North America dominated the market owing to factors such as the increasing prevalence of cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
Tumor Ablation Market Segmentation
Grand View Research has segmented the global tumor ablation market on the basis of technology, treatment, application, and region:
Tumor Ablation Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)
Radiofrequency
Microwave
Cryoablation
Irreversible Electroporation
Other Ablation Technologies
Tumor Ablation Treatment Outlook (Revenue, USD Million, 2016 - 2028)
Surgical ablation
Laparoscopic Ablation
Percutaneous Ablation
Kidney Cancer
Liver Cancer
Breast cancer
Lung Cancer
Prostate Cancer
Other cancers
Kidney Cancer
Liver Cancer
Breast cancer
Lung Cancer
Prostate Cancer
Other cancers
Kidney Cancer
Liver Cancer
Breast cancer
Lung Cancer
Prostate Cancer
Other cancers
Tumor Ablation Application Outlook (Revenue, USD Million, 2016 - 2028)
Kidney Cancer
Liver Cancer
Breast cancer
Lung Cancer
Prostate Cancer
Other cancers
Tumor Ablation Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
U.S.
Canada
U.K.
Germany
France
Italy
Spain
Russia
Netherland
Switzerland
Belgium
Hungary
Japan
China
India
Thailand
South Korea
Taiwan
Singapore
Malaysia
Indonesia
Philippines
Brazil
Mexico
Argentina
Colombia
Chile
South Africa
Saudi Arabia
UAE
Turkey
Israel
List of Key Players of Tumor Ablation Market
Galil Medical Inc.
Misonix Inc.
HealthTronics
Mermaid Medical
Theraclion
Chongqing Haifu Medical Technology Co., Ltd.
HS Hospital Service S.P.A
EDAP TMS S.A.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
0 notes
Text
Tumor Ablation Market Size to Grow at a CAGR of 12.0% During the Forecast Period 2021–2026
"Increasing Adoption of Minimally Invasive Technology for Ablation is Driving the Growth of Tumor Ablation Market."
Tumor Ablation Market size in 2020 was valued at $513.3 billion and is projected to grow with a CAGR of 12.0% during the forecast period 2021-2026. Tumor Ablation is a minimally invasive surgical method commonly used in the treatment of solid cancers. Tumor ablation is undoubtedly the most exciting and high profile procedure currently in Interventional radiology. It is considered a first-line treatment for patients with small hepatocellular carcinomas or benign tumors in the liver. The technique uses elevated temperature to eradicate alleviate blockages or tumors. This therapy can be performed using various techniques such as microwave ablation, radiofrequency ablation, Image Guided Therapy, cryoablation, and other techniques. Among these microwaves, radiofrequency, high-intensity focused ultrasound (HIFU) systems, or laser is used to heat tissue to at least 60°C for maximum efficacy. Increasing prevalence of cancer in worldwide coupled with rising aging population are the major factors driving the growth of the market. Moreover, growing technological advancement in ablation devices coupled with growing demand of minimally invasive surgeries further enhance the overall market demand for Tumor Ablation during the aforesaid period.
Tumor Ablation Market Segment Analysis - By Technology
Based on the Technology, Tumor Ablation Market is segmented into Radiofrequency (Rf) Ablation, Microwave Ablation, Cryoablation, High Intensity Focused Ultrasound (HIFU), Image Guided Therapy, others. The Radiofrequency (Rf) Ablation segment is estimated to dominate the market during the period 2021-2026 and is widely used method of tumor ablation and is also a minimally invasive, repeatable procedure with a low complication rate. The High Intensity Focused Ultrasound (HIFU), segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 6.5% during the period 2021-2026. This is mainly owing to it is most effective non-invasive therapy that uses focused ultrasound waves to thermally ablate a portion of tissue.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=16794
Report Price: $ 4500 (Single User License)
Tumor Ablation Market Segment Analysis - By Mode of Treatment
Based on the Vertebral Position, Tumor Ablation Market is segmented into Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation. In 2020, Surgical Ablation is estimated to hold major share in the market. This is mainly owing to the most effective and well-established treatment option for patients. Moreover, it is a minimally invasive surgical procedure, and it does not involve surgical removal of affected tissues or tumors are also contributing to the dominance of this segment. Also, Laparoscopic Ablation is projected to grow with a CAGR of 7.1% over the period 2021-2026. This is owing to it is more accurate and accessible procedure.
Tumor Ablation Market Segment Analysis - By Geography
North America dominated the Tumor Ablation market share accounting for 41% of the market in 2020. This is mainly due to the presence of key players in U.S. which focus on the development of products with innovative features and greater effectiveness has increased in recent times coupled with rising number of cancer patient in this region. According to, National Cancer Institute, in 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030.
However, the Asia-Pacific region is projected to be the fastest-growing over the period 2021-2026. This is owing to improving healthcare infrastructure coupled with rising advancement in ablation surgery.
Tumor Ablation Market Drivers
Increasing Prevalence of Cancer
Increasing prevalence of cancer across the globe is driving the growth of Tumor Ablation market. According to, World Health Organization (WHO), cancer is the leading cause of death globally and in 2018, around 9.6 million people died owing to cancer in worldwide. Globally, about 1 in 6 deaths is owing to cancer. Moreover, rising number of aging populations is also set to increase the market growth.
Rising Technological Advancement
Increase in research and development of advanced technology for ablation is also driving the market. The advanced technologies such as various imaging-guidance tools that incorporate imaging-fusion between real-time US and CT/MRI, and high-intensity focused ultrasound ablation. Also, the increasing adoption of minimally invasive technology for ablation is also set to the growth of Tumor Ablation Market.
Download Sample Report @ https://www.industryarc.com/pdfdownload.php?id=16794
Tumor Ablation Market Challenges
High capital expenditure required for ablation techniques and strict regulatory by government for launch of ablation devices is challenging the market. Along with this, the uncertainties of reimbursement are also further challenging the growth of the market.
Covid-19 Impact
Moreover, the outbreak of COVID-19 around the world has impacted all industries including healthcare industry. Covid- 19 affects the Tumor Ablation market including drastic reduction in emergency surgical procedures and also overall admission to the Emergency department (ED). Also owing to widespread of coronavirus it affects workforce and staffing issues, procedural prioritisation. These affects Tumor Ablation market by cancellation of scheduled surgery and shift of surgeons to the other area.
Tumor Ablation Industry Outlook
Product launches, Merger & Acquisitions, Joint Ventures and R&D activities are key strategies adopted by players in the Tumor Ablation Market. Tumor Ablation top 10 companies are AngioDynamics Inc., Misonix Inc., NeuWave Medical, Inc., Medtronic PLC, INTIO Inc., SonaCare Medical, LLC, BVM Medical Limited, Theraclion, Boston Scientific Corporation and CONMED Corporation
Acquisitions/Product Launches:
In August 2019, Boston Scientific Corporation received a medical device licence from Heath Canada for ICEfx cryoablation system. ICEfx cryoablation system provides a minimally invasive alternative procedure for patients with certain cancer.
Key Takeaway
In 2020, North America dominated the Tumor Ablation Market owing to rising incidence of cancer.
Increasing various initiatives taken by the government organizations across the globe is also driving the market growth of Tumor Ablation.
Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Tumor Ablation Market report.
High cost of ablation techniques and uncertainties surrounding reimbursement are challenging the growth of the market.
Related Reports :
A. Brain Tumor Treatment Market
https://www.industryarc.com/Report/15949/brain-tumor-treatment-market.html
B. Biliary Tumor Market
https://www.industryarc.com/Research/Biliary-Tumor-Market-Research-509945
For more Lifesciences and Healthcare Market reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
0 notes
Link
Tumor Ablation Devices Market: Introduction
Tumor Ablation is a surgical procedure with minimum invasion to treat solid cancer cells. The minimum invasion surgical procedure uses special probes to freeze and burn the cancer cells. The position of the probe within the tumor is guided by ultrasound, computed tomography (CT) or magnetic resonance imaging. A tiny hole is made in the body to inject the probe in the affected area, which is further attached to the generator that freezes or burns the cancer cells.
Tumor ablation devices such as radiofrequency, microwave, chemical and others are used for treating liver, lung, kidney, prostate and others cancer cells. These therapies will help to provide relief from tumor below 3cm. The treatment with tumor ablation devices facilitates less pain and takes shorter time in recovery than conventional surgical procedures. Moreover, it has lower side effects and lower downs the damages of soft tissues surrounding the tumor cells during the treatment. Therefore, the tumor ablation devices market is anticipated to grow significantly over the projected period owing to rising cancer cases coupled with the evolvement of technology such as high intensity focused ultrasound technology used for treatment.
Request for a sample copy of this report @ https://www.insightsandreports.com/request-sample/277
Market Dynamics
Global tumor ablation devices market is majorly driven by the increasing cases of lung and liver cancer incidences globally. Moreover, the development of the advanced ablation technology for the tumor treatment across the globe, such as irreversible electroporation and microwave ablation are considered to be newer technology in the market, and can treat various types of lung and liver cancers. Numerous animal studies have been facilitated with both type ablation technology. These studies are widely conducted by numerous research organization, globally. For instance, European Organization for Research and Treatment and University of Miami are facilitating various studies on these technologies. Other sprouting technologies include high intensity focused ultrasound and stereotactic body radiation.
Technology Insights
Radiofrequency ablation technology is anticipated to dominate the global tumor ablation devices market over the projected period, owing to the rising lung and liver cancer, due to rise in tobacco and alcohol consumption. According to the World Health Organization, the estimated number of cases and deaths of lung cancer by the end of 2018 accounts for approximately 2.09 million cases and 1.76 million deaths, respectively.
Furthermore, the microwave ablation technology is expected to have substantial growth in the global tumor ablation devices market during the forecast period, attributed by the various benefits being offered. As, reduces the procedural pain, decreases the destruction of soft tissue surrounding the tumor coupled with the faster heat generation and thus, reduces the probability to damage the associated organs in the body.
Application Insights
Lung cancer treatment using ablation technology is perceived to hold one of the key application areas followed by liver cancer in the global tumor ablation devices market over the forecast period, owing to rising number of lung and liver cancer patients across the globe thereby resulting in development of newer technology such as microwave ablation technology. Owing to which there is increase in the adoption microwave ablation technology by healthcare professionals. For instance, University of California San Francisco is one of the cancer centers which offers microwave ablation for the treatment of liver cancers such as primary liver cancer including hepatocellular carcinoma which is associated with hepatitis B and C and cirrhosis. The university also treats secondary liver cancer using microwave ablation such as metastatic.
Regional Insights
North America tumor ablation devices market is anticipated to account major share across the globe, particularly contributed by the U.S. This is majorly due to the increasing replacements of the conventional ablation technology with the newer ablation technology for the treatment of tumors. For instance, EDAP TMS developed high intensity focused ultrasonic systems in 2016. It is a robotic device that facilitates the ablation of prostate tumor. This novel ablation device is available in numerous institutes such as University of Miami, the Cleveland Clinic, USC in Los Angeles (LA) and others for contributing in the awareness of the ablation device in the U.S.
Asia Pacific tumor ablation devices market is anticipated to be fastest growing region over the forecast period, primarily attributed by the growing healthcare infrastructure to cure numerous diseases including tumors in this region. The growth is majorly witnessed in developing countries such as India and China owing to the initiatives taken by the government towards the healthcare industry. According to India Brand Equity Foundation, the total size of industry is expected to reach US$ 372 billion by 2022 from US$ 160 billion in 2017.
For more information about this report @ https://www.insightsandreports.com/industry-reports/tumor-ablation-devices-market
Competitive Landscape
Key players operating in the global tumor ablation devices market include Medtronic Plc, SonaCare Medical, LLC, Johnson & Johnson, Intuitive Surgical, Galil Medical Inc., Alpinion Medical Systems Co., Ltd., Smith & Nephew Plc, Abbott Laboratories, Boston Scientific Corporation, and several others.
Mergers & Acquisitions, product launch and development, partnership & collaborations are the key undertakings of the companies to improve their presence in the global tumor ablation devices market. For instance, NeuWave Medical Inc., a leading manufacturer of microwave ablation devices was acquired by Ethicon, a Johnson & Johnson Company in 2016 to increase its product portfolio in tumor ablation devices.
1 note
·
View note
Text
Global Absorbable Tissue Spacer Market is estimated to witness tremendous progress through 2029 | FMI
Radiation therapy or particle therapy is exhibited as a more promising treatment option for cancer treatment. Radiation therapy also affects the adjacent organs or make delivery of doses too difficult because numerous radiation morbidities might occur. Absorbable tissue spacer is introduced to overcome the therapeutic and anatomical problems and deliver effective radiation doses. Absorbable tissue spacer is effective to block particle beams and separate normal tissue from the radiation field. Absorbable tissue spacer has reduced the effect of radiation therapy on adjacent organs. Absorbable tissue spacer is Bioabsorbable spacer which injected into place before to start of radiation treatment.
Absorbable tissue spacer remains stable during radiation therapy and slowly absorbed by the body after radiotherapy has been completed. Nonwoven fabric spacer, absorbable polyglycolic acid (PGA) and absorbable hydrogel spacer are some of the absorbable tissue spacers. Absorbable tissue spacer such as absorbable hydrogel spacer is used during prostate radiotherapy to create distance between the prostate and the rectum. Prostate cancer is one of the most common cancer types in men. Absorbable polyglycolic acid (PGA) spacers are effective to treat upper abdominal tumors. Absorbable tissue spacer such as PGA spacers is majorly used for pancreatic cancer which used to keep away gastrointestinal tract from radiation.
Absorbable Tissue Spacer Market: Drivers and Restraints-
The increasing prevalence of prostate cancer expected to drive the growth of the absorbable tissue spacer market. National Cancer Institute estimated that 164,690 new cases of prostate cancer in 2018. High adoption of radiation therapy or chemotherapy to treat cancer are expected favors the growth of the absorbable tissue spacer market. Increasing number of cases of pancreatic cancer expected to spur the demand for radiation therapy and favors the growth of the absorbable tissue spacer market. According to the American Cancer Society estimated 55,440 people will be diagnosed with pancreatic cancer in 2018. Growing development of new technology and products for effective cancer treatment expected to drive the growth of the absorbable tissue spacer over the forecast period.
Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8507
Absorbable Tissue Spacer Market: Segmentation
On the basis of product type, absorbable tissue spacer market can be segmented as:
Absorbable Polyglycolic Acid (PGA) Spacers
Absorbable Hydrogel Spacer
On the basis of application, absorbable tissue spacer market can be segmented as:
Pancreatic Cancer
Liver Cancer
Prostate Cancer
Others
On the basis of the end user, the absorbable tissue spacer market can be segmented as:
Hospitals
Cancer Treatment Centers
Cancer Research Centers
Absorbable Tissue Spacer Market: Overview
Absorbable tissue spacer is Bioabsorbable tissue spacer used for protection of adjacent tissue during the radiation therapy. Absorbable tissue spacer is made from nonwoven fabric and hydrogel which exhibit the more focused effect on the target tissue. Absorbable tissue spacer is used for providing appropriate protection and create strong protection barriers. Absorbable tissue spacer is expected to create strong demand for prostate cancer.
Absorbable Tissue Spacer Market: Region-wise Outlook
In terms of geography, the market has been divided into seven regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding & Japan (APEJ), Japan, Middle-East & Africa, and Latin America. North America is the most dominating market for absorbable tissue spacer market due to high prevalence of prostate cancer in United States. According to National Cancer Institute, in 2015 around 3,120,176 men living with prostate cancer in United States. Western European expected to contribute second largest revenue share in absorbable tissue spacer market due to high adoption radiation therapy for cancer treatment and growing demand of technologically advanced products. The Asia Pacific excluding Japan absorbable tissue spacer market is expected to gain a high growth rate over the forecast period due to increasing healthcare spending and government support for cancer treatment.
Absorbable Tissue Spacer Market: Key Market Participants
Example of some market players participants in global absorbable tissue spacer market identify across the value chain are Boston Scientific Corporation (Augmenix Inc.) and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes:
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia Pacific (India, China ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Speak to Analyst, Questions Related To Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-8507
Reasons to Buy the report
We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.
FMI’s Healthcare Research Reports:
Microwave Ablation Devices Market
Tumour Ablation Devices Market
Cardiac Surgery Devices Market
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
0 notes
Text
Carcinoid Tumor Market Research Report - Global Forecast Till 2027
Carcinoid Tumor Market Research Report, Site (Lung, Gastrointestinal), Diagnosis (Serology, Imaging, Biopsy), Treatment (Chemotherapy, Radiotherapy), End Users (Hospital & Clinics, Academic Institutes, Research Organization) - Global Forecast Till 2027
Market Highlights
Carcinoid tumor is a type of the neuroendocrine tumor. The most common site of carcinoid tumors is the GI (gastrointestinal) tract and the lungs. However, it can also be developed in pancreas, testicles, and ovaries. The increasing prevalence of the carcinoid tumor is expected to drive the market growth. According to the American Society of Clinical Oncology (ASCO) in 2016, approximately 8,000 adults in the US were diagnosed with a carcinoid tumor in their GI tract. Moreover, it was also estimated that each year approximately 4,000 adults in the US are diagnosed with a carcinoid tumor in their lung. Moreover, growing geriatric population along with rising healthcare expenditure is likely to boost the market growth during the forecast period. However, lack of awareness, high treatment cost and related side effects may hamper the market growth during the forecast period.
Segmentation
The global carcinoid tumor market is segmented on the basis of site, diagnosis, treatment, and end users.
On the basis of the site, the market is segmented into gastrointestinal, lung, and others. Furthermore, the gastrointestinal segment is sub-segmented into rectum, small intestine, appendix, and others. Lung segment is sub-segmented into typical, atypical, and others.
On the basis of the diagnosis, the market is segmented into serology, imaging, biopsy, and others. The serology segment is sub-segmented into blood test, urine test, molecular test, and others. The imaging segment is sub-segmented into X-ray, CT scan, PET scan, and others.
On the basis of the treatment, the market is segmented into surgery, chemotherapy, radiotherapy, and others. The surgery segment is sub-segmented into local excision, radiofrequency ablation (RFA), and others.
On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, research organization, and others.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4813
Regional Analysis
America dominates the global carcinoid tumor market owing to a well-developed healthcare sector and huge patient population. Apart from this, increasing healthcare expenditure and presence of developed economies like the U.S. and Canada within the region have boosted the growth of the market in America.
Europe is the second leading market across the globe, which is followed by Asia Pacific owing to availability of funds for research, huge patient population, and strong government support for research & development. According to the National Health Service in 2015, each year about 1,200 people are diagnosed with carcinoid tumor in the UK.
Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies like India and China, which have rising healthcare expenditure. Moreover, favorable governmental policies and the presence of huge opportunity in the untapped market within the region are likely to fuels the market growth during the forecast period.
On the other hand, the Middle East & Africa holds the least share in the global carcinoid tumor market due to presence of poor economy, especially, in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. The presence of developed economies like Qatar, Saudi Arabia, Dubai, and others within the region fuels the market growth.
Key Players
Some of the key players in the global carcinoid tumor market are Novartis AG (Europe), Amgen Inc. (U.S.), Boehringer Ingelheim GmbH (Europe), AVEO Pharmaceuticals, Inc. (U.S.), Chiasma, Inc. (U.S.), Aegis Therapeutics, LLC (U.S.), CRINETICS PHARMACEUTICALS (U.S.), Delcath Systems Inc. (U.S.), Exelixis, Inc. (U.S.), and others.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/carcinoid-tumor-market-4813
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Related Report:
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Global Tumor Ablation Market – Analysis and Forecast (2018-2024)
Ablation is the method to destroy a tumor without removing it, which is used in patients with few small tumors when surgery is not preferred. The global tumor ablation market is growing at a significant rate due to the increasing prevalence of cancer, and rapid growth in the geriatric population. Different types of technology contributed to the tumor ablation industry size. The market has witnessed extreme demand for radiofrequency ablation over the last few years, due to the easiness of treatment and continuing growths of technologically innovative radiofrequency tumor ablation.
For Free Sample Report- https://www.vynzresearch.com/healthcare/tumor-ablation-market/request-sample
Industry Trends
Mounting adoption of microwave technology and radiofrequency-based tumor ablation procedures are the major trends of the tumor ablation market. In radiofrequency-based ablation, high-frequency electrical currents are passed through an electrode in the needle, creating a small region of heat that destroys the cancer cells.
Growth Drivers
The rapidly expanding aging population, escalating occurrence of cancer, and technological improvement in ablation devices are the primary growth drivers for the tumor ablation market. For instance, according to GLOBOCAN globally, approximately 14.1 million new cancer cases were diagnosed and there were 8.2 million cancer deaths in 2012. In addition, according to World Health Organization (WHO), in 2015 approximately 8.8 million people died due to cancer. Moreover, approximately 70% of the deaths from cancer occur in low and middle-income countries.
The escalating number of hospitals, surgical and ablation centers and mounting market demand for minimally invasive ablation techniques are also fueling the growth of the tumor ablation market. Minimally invasive surgery procedure includes assistances such as fast recovery and reduced trauma.
Boosting attentiveness about ablation procedures, technological improvement in the field of ablation focused on security and improving the efficiency of the treatment, and expanding the number of private-public initiatives and finance to support continuing research activities are also driving the growth of the market.
Geographic Overview
Geographically, North America is the largest tumor ablation market due to the mounting occurrence of cancer, boosting government funding for cancer research, expanding geriatric population, and intensifying the need for a minimally invasive procedure for cancer treatment. For instance, according to GLOBOCAN in the U.S., approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.
Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of largest population. In addition, growing medical tourism, expanding geriatric population, boosting government initiatives for the reconstruction of healthcare infrastructure, and minimally invasive surgical procedures are also creating a positive impact on the tumor ablation market growth in the region.
Competitive Insight
Key players in the industry are investing in the development of innovative and advance ablation products, which is strengthening their position in the market. In April 2018, Medtronic launched the OptiShere embolization sphere designed for the embolization of hypervascular tumors in the U.S.
In addition, in April 2018 Medtronic launched the Visualase MRI-Guided Laser Ablation System, to provide advanced MRI-guided laser ablation technology in Europe. Medtronic, PLC, Angiodynamics, Inc., Healthtronics, Inc., Galil Medical, Inc., Boston Scientific Corporation, Neuwave Medical, Inc., Edap TMS S.A., Mermaid Medical A/S, Sonacare Medical, LLC, and Misonix, Inc. are some of the key players offering ablation products.
For Customization Request -https://www.vynzresearch.com/healthcare/tumor-ablation-market/customize-report
VynZ Research
Call: +91-996-028-8381
Toll Free (U.S. and Canada): +1-888-253-3960
Email: [email protected]
Web: https://www.vynzresearch.com
Connect with Us: LinkedIn | Facebook | Twitter
VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT, and other emerging technologies. READ MORE…
0 notes
Text
Immuno Oncology (I-O) Market Evolving Opportunities, Covid-19 Impact, Strategies And Forecast
The report “Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 according to a new study by Polaris Market Research. Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. Currently, world is at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers, as well as an approved immuno-oncology medicine that continues to be studied for new uses. The more precise targeting of patients for selected therapies is another important area of focus in oncology. Clinical biomarkers and pharmacogenomic studies are increasingly used to identify groups and sub-groups of patients most likely to benefit from an investigational agent in order to maximize its potential benefits.
Get Sample PDF @ https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/request-for-sample
Some of the key players operating in global immuno-oncology market are Bristol Myers Squibb, Merck, AstraZeneca, Roche Holding AG, Pfizer Inc., and Incyte Corporation among others.
The global immuno-oncology market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of immune oncology for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional treatment procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the developments in oncology treatments, leading to the increased development of pioneering products are also advancing towards significant growth of the global Immune Oncology market.
The increasing trend was also seen in the research in the novel agents and increase in the number of clinical trials in combinations as well as monotherapy. The most notable new agents in Immuno-Oncology are IDO’s, LAG-3, TIGIT, TIM-3, VISTA, KIR, NKG2A, B7-H3/H4. The Report has also emphasized on the Oncolytic viruses, Neo-Antigen therapies, TCR Therapies and CAR-T therapies.
Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/request-for-discount-pricing
On the basis of treatment type, the global immuno-oncology market is segmented into Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines. Checkpoint inhibitors were the largest treatment process segment in 2019 that accounted for 55.2% of the overall revenue. On the basis of novel targets, the global market is segmented into IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i. VEGFi was the largest novel target segment that was used for immuno-oncology treatment processes in 2019 with a total market share of 11.2%. on the basis of cancer type, the global immuno-oncology Market is segmented into Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Head, face & Neck Cancer, Bladder Cancer, Classical Hodgkin’s Lymphoma, Merkel Cell, and carcinoma. Revenue share of immuno-oncology treatment for classical hodgkin’s lymphoma was the largest in 2019 i.e. 15.31% among the listed tumor types in the report.
On the basis of geography, North America was the largest regional market in 2019. High levels of spending on cancer treatments, also U.S. being one of the major country y with a huge population of cancer affected people on a global scale, the country being the host to the development of this technology, higher frequency of innovations of immuno oncology treatments or processes in the region specially in the U.S. etc., all of these factors have driven significant investment and alongside the demand for IO in the region. These factors have driven the North American market since the inception of this technology and over the forecast period it is expected to increase further.
Buy Now : https://www.polarismarketresearch.com/checkouts/751
0 notes
Text
Tumor Ablation Market , Outlook, Industry Demand and Supply, Key Prospects, Pricing Strategies, Forecast and Top Manufacturers Analysis Report
The report on the global Tumor Ablation Market published by Reports and Data provides an in-depth assessment of the Tumor Ablation market including recent technological and product advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, and other key features. The report comprises 100+ pages and covers comprehensive assessment of market size, market share, revenue contribution, revenue share, growth rate, industrial chain analysis, regional analysis, and top companies. It also provides strategic recommendations to formulate investment strategies and provides insights for new entrants.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2029
The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.
Key players in the market include
Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc.
For a better understanding of the global Tumor Ablation market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market. It provides insights into production and consumption patterns, supply and demand ratio, export/import, current and emerging trends and demands, market share, market size, revenue contribution, and presence of key players in each region.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2029
In-depth regional analysis includes:
· North America (U.S., Canada, Mexico)
· Europe (Italy, U.K., Germany, France, Rest of EU)
· Asia Pacific (India, China, Japan, South Korea, Australia, Rest of APAC)
· Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
· Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Furthermore, the report segments Tumor Ablation market on the basis of key product types and applications and provides details about the revenue growth, revenue CAGR, and revenue share each segment is expected to register over the forecast period.
Treatment Type Outlook (Revenue, USD Million; 2016-2026)
Surgical Ablation
Laparoscopic Ablation
Percutaneous Ablation
Technology Type Outlook (Revenue, USD Million; 2016-2026)
Radiofrequency Ablation
Cryoablation
Microwave Ablation
Irreversible Electroporation
Other Ablation Technologies
Application Type Outlook (Revenue, USD Million; 2016-2026)
Liver Cancer
Lung Cancer
Breast cancer
Prostate Cancer
Other Cancer
To know more about the report @ https://www.reportsanddata.com/report-detail/tumor-ablation-market
Benefits of the Global Tumor Ablation Report:
• Comprehensive analysis of the opportunities and risks of the Tumor Ablation market
• Detailed study of the latest product and technological developments and innovations of the Tumor Ablation market
• Business strategies and plans are analysed for understanding the Tumor Ablation market scenario
• Revenue forecast of Tumor Ablation market for the forecast period 2020-2028
• Comprehensive analysis of the drivers, constraints, limitations, challenges, and opportunities
• Latest and emerging market trends analysis and their impact on product and application demand
• Study of recent M&A, joint ventures, collaborations, partnerships, product launches and brand promotions among others
• Extensive SWOT analysis and Porter’s Five Forces analysis along with investment return analysis and feasibility
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2029
Thank you for reading our report. Please get in touch with us to know more about the report and customization of the report. Our team will ensure the report is tailored to meet your requirements.
0 notes
Text
Surgical Tumor Ablation Market Analysis and Forecast to 2028
Global Surgical Tumor Ablation Market, By Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryoablation, Others), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Liver Cancer, Brain Cancer, Lung Cancer, Prostate Cancer, Bone Metastasis, Others), End User (Hospital, Surgical and Ablation Centers, Research Institute, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
An expert team performs systematic, object-oriented and complete market research study to provide the facts associated with any subject in the field of marketing via Surgical Tumor Ablation marketing report. The report has a lot to offer to both established and new players in the Surgical Tumor Ablation industry with which they can completely understand the market. SWOT analysis and Porter’s Five Forces analysis methods are used wherever applicable, while generating this report. One of the most important parts of an international Surgical Tumor Ablation market report is competitor analysis with which businesses can estimate or analyse the strengths and weaknesses of the competitors.
Key Players
The major players covered in the surgical tumor ablation market report are AngioDynamics, Boston Scientific Corporation, Medtronic, EDAP TMS, HealthTronics, Inc., Misonix, Johnson & Johnson Services, Inc., Sonacare Medical, BIOTRONIK SE & Co KG., COMSOL INC., Erbe Elektromedizin GmbH, Smith & Nephew, Abbott, CONMED Corporation, HealthTronics, Inc., MERMAID MEDICAL A/S, Integra LifeSciences Corporation, BVM Medical Ltd., CooperSurgical Inc., and AtriCure, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Browse More Info @ https://www.databridgemarketresearch.com/reports/global-surgical-tumor-ablation-market
With the help of credible Surgical Tumor Ablation market analysis report, businesses can make out the reaction of the consumers to an already existing product in the market. The report includes estimations of recent state of the market, CAGR values, market size and market share, revenue generation, and necessary changes required in the future products. A wide-ranging competitor analysis helps build superior strategies of production, improvement in certain product, its advertising or marketing and promotion for the business. Exhaustive and comprehensive market study performed in the wide ranging Surgical Tumor Ablation market report offers current and forthcoming opportunities that put light on the future market investment.
Key questions answered in the report:
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
Report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Surgical Tumor Ablation Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Table Of Content
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Global Market
Part 04: Global Market Size
Part 05: Global Market Segmentation By Product
Part 06: Five Forces Analysis
More Reports:
Diuretic Drugs Market
Patient Engagement Technology Market
Healthcare Business Intelligence Market
Chinese Hamster Ovary cells (CHO) Market
Anti-cancer Drug Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
Ablation Devices Market Trends 2022 | North America, Europe, & APAC Industry Forecasts 2028
Ablation Devices Market is grow at a CAGR 11.25% in the forecast 2021 to 2028.
Ablation Devices Market Scope and Size
· On the basis of product, the ablation devices market is segmented into laser ablators, radiofrequency ablators, microwave ablators, ultrasound ablators, electric ablators, hydrothermal ablators and cryoablators. Laser ablators have further been segmented into excimer laser ablators and cold laser ablators. Radiofrequency ablators have further been segmented into temperature-controlled radiofrequency ablators, fluid-cooled radiofrequency ablators and robotic catheter manipulation systems. Ultrasound ablators have further been segmented into high-intensity focused ultrasound (HIFU) ablators, magnetic resonance-guided focused ultrasound (MRGFUS) ablators, ultrasonic surgical ablation systems and extracorporeal shockwave lithotripsy (ESWL) systems. Electric ablators have further been segmented into argon plasma/beam coagulators and irreversible electroporation ablators. Hydrothermal ablators have further been segmented into endometrial hydrothermal balloon ablation devices. Microwave ablators have further been segmented into microwave thermotherapy devices. Cryoablators have further been segmented into tissue contact probes, tissue spray probes and epidermal and subcutaneous cryoablation devices.
· On the basis of technology type, the ablation devices market is segmented into radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation and others.
· On the basis of function, the ablation devices market is segmented into automatic and robotic.
· On the basis of procedure, the ablation devices market is segmented into tumor ablation, varicose veins, atrial fibrillation and aesthetics-skin rejuvenation and tightening, laser and other energy based therapies.
Get the sample copy of Report here https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ablation-devices
Global Ablation Devices Market Country Level Analysis
The ablation devices market is analyzed and market size insights and trends are provided by country, product, technology type, function, procedure and application as referenced above.
The countries covered in the global ablation devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Competitive Landscape and Ablation Devices Market Share Analysis
The ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to ablation devices market.
MAJOR TOC OF THE REPORT
Chapter One: Ablation Devices Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three : Ablation Devices Market Competition, by Players
Chapter Four: Global Ablation Devices Market Size by Regions
Chapter Five: North Ablation Devices Market by Countries
Chapter Six: Europe Ablation Devices Market Revenue by Countries
Chapter Seven: Asia- Ablation Devices Market Revenue by Countries
Chapter Eight: South America Ablation Devices Market Revenue by Countries
Chapter Nine: Middle East and Ablation Devices Market Revenue Equipment by Countries
Chapter Ten: Global Ablation Devices Market Segment by Type
Chapter Eleven: Global Ablation Devices Market Segment by Application
Get TOC Details: https://www.databridgemarketresearch.com/toc/?dbmr=global-ablation-devices-market
The major players covered in the ablation devices market report are Varian Medical Systems Inc., Biosense Webster, Inc., Elekta AB, Medtronic, Johnson & Johnson Services, Inc., Alcon, Bausch & Lomb Pvt Ltd., EDAP TMS, Halyard, Olympus Corporation, Abbott, AngioDynamics, AtriCure, Inc., Boston Scientific Corporation and CONMED Corporation among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Access Full Report https://www.databridgemarketresearch.com/reports/global-ablation-devices-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
Stem Cell manufacturing Market
Revenue Cycle Management (RCM) Market
0 notes
Text
Tumor Ablation Market is expected to reach US$ XX Mn by 2026 at a CAGR of XX % during the forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
Tumor ablation is a minimally invasive cancer procedure. That is generally used in the treatment of tumors of liver, kidney, bone, and lung. In the tumor ablation procedure, special probes are used to burn or freeze tumor without the surgery. Tumor ablation is a device operated to treat cancerous malignancy. Tumor ablation is the process of removing the cancerous cells from the body.
High prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis), the Rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research would create commercial market opportunities. The hugely unused markets in the developing countries are creating a lot of opportunities for the tumor ablation market. Furthermore, unfavorable reimbursement scenario and cost containment measures adopted by a government are the major hindrance of the market growth.
Tumor Ablation market is segmented by technology, mode of treatment, application, and region. Among technology, microwave ablation and radiofrequency (RF) ablation is expected to grow at the fastest rate owing various benefits offered by this technology. This technology would continue to dominate the market during the forecast period owing to increasing demand for minimally invasive cancer procedures. Radiofrequency ablation technology is the most commonly used therapy for liver cancer. It will grow at a significant rate due to approximately XX% and more success rate for eliminating small liver tumors. Among applications, liver cancer segment is predicted to grow at fastest rate due to the rise in the incidence of the bile duct and primary liver cancer.
Among regions, the North America region is expected to grow at the highest CAGR of XX% during the forecast period due to the remarkably advanced healthcare industry with higher healthcare spending and adoption of innovative science & technology. The APAC region is expected to grow at the highest CAGR of XX% during the forecast period due to the increasing elderly population in the region. The high percentage of the elderly population in developing countries such as China and Japan are increasing the incidence of major types of cancer in the Asia Pacific region. Rising per capita income, rapid urbanization, and expansion of advanced healthcare facilities in developing economies are likely to offer profitable opportunities to vendors in tumor ablation market.
The objective of the report is to present a comprehensive analysis of Global Tumor Ablation Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Tumor Ablation Market dynamics, structure by analyzing the market segments and project the Global Tumor Ablation Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Global Tumor Ablation Market make the report investor’s guide.
visit at-https://www.maximizemarketresearch.com/market-report/tumor-ablation-market/12788/
Scope of the Tumor Ablation Market :
• Tumor Ablation Market, by Technology
• Radiofrequency (RF) Ablation
• Microwave Ablation
• Cryoablation
• Other Technologies
• Tumor Ablation Market, by Mode of Treatment
• Percutaneous Ablation
• Laparoscopic Ablation
• Surgical Ablation
• Tumor Ablation Market, by Application
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastasis
• Others
• Tumor Ablation Market by region
• North America
• Europe
• APAC
• Latin America
• MEA
Key Players- Tumor Ablation Market
• Medtronic plc
• Angiodynamics, Inc.
• Koninklijke Philips N.V
• Spectranetics, Boston Scientific Corporation
• Galil Medical, Inc.
• EDAP TMS S.A.
• Healthtronics, Inc.
• Medtronic, Plc
• Mermaid Medical, Inc.
• Mesonix, Inc.
• Neuwave Medical, Inc.
• Sonacare Medical, LLC (U.S.)
About Us:
Maximize Market Research provides B2B and B2C market research on
20,000 high growth emerging technologies & opportunities in Chemical,
Healthcare, Pharmaceuticals, Electronics & Communications, Internet of
Things, Food and Beverages, Aerospace and Defense and other
manufacturing sectors.
0 notes
Text
Immuno-Oncology Market Analysis by Essential Factors and Trends In Industry by 2025
The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 according to a new study by Polaris Market Research. The report “Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function.
Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. Currently, world is at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers, as well as an approved immuno-oncology medicine that continues to be studied for new uses. The more precise targeting of patients for selected therapies is another important area of focus in oncology. Clinical biomarkers and pharmacogenomic studies are increasingly used to identify groups and sub-groups of patients most likely to benefit from an investigational agent in order to maximize its potential benefits.
Request for a sample copy of this research report @ https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market/request-for-sample
The global immuno-oncology market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of immune oncology for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional treatment procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the developments in oncology treatments, leading to the increased development of pioneering products are also advancing towards significant growth of the global Immune Oncology market.
The increasing trend was also seen in the research in the novel agents and increase in the number of clinical trials in combinations as well as monotherapy. The most notable new agents in Immuno-Oncology are IDO’s, LAG-3, TIGIT, TIM-3, VISTA, KIR, NKG2A, B7-H3/H4. The Report has also emphasized on the Oncolytic viruses, Neo-Antigen therapies, TCR Therapies and CAR-T therapies.
On the basis of treatment type, the global immuno-oncology market is segmented into Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines. Checkpoint inhibitors were the largest treatment process segment in 2019 that accounted for 55.2% of the overall revenue. On the basis of novel targets, the global market is segmented into IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i. VEGFi was the largest novel target segment that was used for immuno-oncology treatment processes in 2019 with a total market share of 11.2%. on the basis of cancer type, the global immuno-oncology Market is segmented into Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Head, face & Neck Cancer, Bladder Cancer, Classical Hodgkin’s Lymphoma, Merkel Cell, and carcinoma. Revenue share of immuno-oncology treatment for classical hodgkin’s lymphoma was the largest in 2019 i.e. 15.31% among the listed tumor types in the report.
On the basis of geography, North America was the largest regional market in 2019. High levels of spending on cancer treatments, also U.S. being one of the major country y with a huge population of cancer affected people on a global scale, the country being the host to the development of this technology, higher frequency of innovations of immuno oncology treatments or processes in the region specially in the U.S. etc., all of these factors have driven significant investment and alongside the demand for IO in the region. These factors have driven the North American market since the inception of this technology and over the forecast period it is expected to increase further.
Some of the key players operating in global immuno-oncology market are Bristol Myers Squibb, Merck, AstraZeneca, Roche Holding AG, Pfizer Inc., and Incyte Corporation among others.
Complete Summary with TOC Available @ https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market
Polaris Market research has segmented the Immuno-oncology market report on the basis of Treatment Approaches, novel targets, tumor types, and by region
Immuno-Oncology Treatment Approach Outlook (Revenue, USD Million, 2015 – 2025)
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Cytokines
Immuno-Oncology Novel Target Outlook (Revenue, USD Million, 2015 – 2025)
IDO1i
LAG-3 CPI
Oncolytic virus
STING agonist
TLR agonist
HDACi
TIL
VEGFi
MEKi
TIGIT
CPI
GITR agonist
TGF-b trap
A2AR antagonist/CD73i
Immuno-Oncology Tumor Type Outlook (Revenue, USD Million, 2015 – 2025)
Melanoma
Non-Small Cell Lung Cancer
Renal Cell Carcinoma
Head & Neck Cancer
Bladder Cancer
Classical Hodgkin’s Lymphoma
Merkel Cell Carcinoma
Others
Immuno-Oncology Regional Outlook (Revenue, USD Million, 2015 – 2025)
U.S.
Canada
Germany
UK
China
India
Japan
Mexico
Purchase This Report @: https://www.polarismarketresearch.com/checkouts/751
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
Web: www.polarismarketresearch.com
0 notes